Moreover, this compound was observed to decrease the migratory and invasive capabilities of these HCC cells in a dose-dependent (6.6 μg/mL–10 μg/mL) manner, by suppressing the expression of MMP-2 and MMP-9, as well as by inhibiting the EGFR/NF-kB pathway [55]. The gene discussed is MMP9; the disease is hepatocellular carcinoma.